News aXichem AB

Stocks

AXIC A

SE0005250719

Specialty Chemicals

Market Closed - Nasdaq Stockholm 17:00:00 15/09/2026 BST			5-day change	1st Jan Change
1.725 ^SEK	-6.25%		-5.74%	-16.67%

08-27	AXichem AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-26	Calendar Thursday, August 27	FW

All News

Mentions Relevance

09-08	AXichem : notes growing commercial adoption in Brazil for aXiphen ruminant as Garra Nutrição increases volume to four tonnes	PU
08-27	AXichem AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-24	AXichem : CEO Torsten Helsing Presents the Report for the Second Quarter 2026 in a Live Web Conference	PU
08-24	AXichem : CEO Torsten Helsing Presents the Report for the Second Quarter 2026 in a Live Web Conference	PU
07-24	AXichem's Salmonella-inhibiting Chicken Feed Additive Gets EU Agency Backing	MT
07-24	AXichem : receives positive scientific opinion from EFSA for phenylcapsaicin as a salmonella-inhibiting additive in chicken feed	PU
06-26	AXichem Receives Order for Feed Additives for SEK4.2 Million	MT
06-26	AXichem : receives order for aXiphen from Chr. Olesen in Brazil to a value of SEK 4.2 million, for use in feed for chickens and ruminants	PU
06-17	Axichem AB Elects Michael Engstrom As Chairman Of The Board	RE
05-21	Axichem Q1 operating loss narrows to SEK 2.8 mln	RE
05-21	AXichem AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-15	Axichem proposes chairman	RE
05-07	Axichem launches axiphen ruminant in Brazil	RE
04-09	AXichem: Final study report shows aXiphen improves milk production	RE
03-18	Sweden's aXichem Secures Product Registration for Phenylcapsaicin Cattle Feed Additive in Brazil	MT
03-18	Axichem gets product registration in Brazil	RE
03-10	Axichem carries out directed issue of units in connection with completed rights issue	RE
03-02	Axichem announces final outcome of rights issue	RE
02-27	AXichem : announces preliminary outcome of the rights issue	PU
02-19	Axichem Oct-Dec net sales SEK 3.84 million	RE
02-19	AXichem AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
02-04	AXichem carries out rights issue of units of about SEK 11 mln	RE
01-15	AXichem AB Announces Publication of CrossFit Study in Leading Sports Journal - Validates aXivite as a High-Intensity Performance Supplement	CI
12-08	AXichem delivers to Brazil, order worth SEK 7 million	RE
11-28	Axichem Q3 net sales SEK 4.5 million	RE